Information Provided By:
Fly News Breaks for March 12, 2015
Mar 12, 2015 | 15:11 EDT
H.C. Wainwright said the CPT panel of the American Medical Association accepted submission of new codes to cover MELA Sciences' MelaFind system ahead of the firm's expectation of the second half of this year. Once the codes have been approved, MELA can start the process of applying for reimbursement with individual insurers and possibly get approval by the end of 2015, the firm noted. H.C. Wainwright maintains its Buy rating and $4.50 price target on MELA shares.
News For MELA From the Last 2 Days
There are no results for your query MELA
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.